naringenin은 임신 중 안전한가요?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for naringenin (CAS 480-41-1). Peer‑reviewed literature shows naringenin is a dietary citrus flavanone with some in vitro endocrine-related activity reported, but no consistent animal or human developmental/teratogenic signal that would trigger H361/H360 classification; therefore hazard and mechanism are scored 0. Percutaneous absorption from topical application is plausible (low, not negligible) given naringenin’s physicochemical properties and presence in cosmetic formulations, so exposure is scored as low but measurable (e=1). Sources consulted: ECHA (no harmonised CLP entry), PubChem, PubMed, CosIng, EWG.
Pregnancy-safe products containing naringenin










Related ingredients
Frequently asked questions
- naringenin은 임신 중 안전한가요?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for naringenin (CAS 480-41-1). Peer‑reviewed literature shows naringenin is a dietary citrus flavanone with some in vitro endocrine-related activity reported, but no consistent animal or human developmental/teratogenic signal that would trigger H361/H360 classification; therefore hazard and mechanism are scored 0. Percutaneous absorption from topical application is plausible (low, not negligible) given naringenin’s physicochemical properties and presence in cosmetic formulations, so exposure is scored as low but measurable (e=1). Sources consulted: ECHA (no harmonised CLP entry), PubChem, PubMed, CosIng, EWG.
- naringenin은 모유 수유 중 안전한가요?
- Same rationale as for pregnancy: no harmonised reproductive classification and no authoritative CIR/SCCS contraindication identified. Potential for low systemic absorption after topical use implies low measurable exposure in breastfeeding parent (e=1). No specific data on milk transfer were found in the authoritative sources consulted.
- naringenin은 아기 피부에 안전한가요?
- No infant‑specific developmental toxicity or dermal‑toxicity data indicating increased hazard. Following the specified instruction to increase exposure for infants when adult topical absorption is measurable, baby exposure is increased by +1 (adult e=1 → baby e=2) because infant skin has higher permeability and greater surface‑area‑to‑weight ratio. Hazard and mechanism remain 0 in absence of infant‑specific evidence.
- VeriMom은 naringenin을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 naringenin을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 naringenin 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.